MNMD icon

MindMed
MNMD

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$24
92% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Canaccord Genuity
Canaccord Genuity
Sumant Kulkarni
100% 1-yr MNMD win rate
7 Nov ‘25 22 days ago
RBC Capital
RBC Capital
Brian Abrahams
100% 1-yr MNMD win rate
7 Nov ‘25 22 days ago
Needham
Needham
Ami Fadia
100% 1-yr MNMD win rate
13 Oct ‘25 1 month ago